Aarti Drugs Ltd (AARTIDRUGS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 657348, "name": "Aarti Drugs", "stock_name": "Aarti Drugs", "full_name": "Aarti Drugs Ltd", "name_url": "stocks-analysis/aarti-drugs", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "387.90", "chg": -9.75, "chgp": "-2.45%", "dir": -1, "prev_price": "397.65", "mcapval": "3,614.00 Cr", "mcap": "Small Cap", "scripcode": 524348, "symbol": "AARTIDRUGS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE767A01016", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "1.44 lacs", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-drugs-657348-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Aarti Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-by-marketsmojo-3975745", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiDrugsLtd_mojoScore_3975745.png", "date": "2026-05-05 10:10:34", "description": "Aarti Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the most recent insights into the company’s performance and outlook." }, { "title": "Aarti Drugs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-3960622", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiDrugsLtd_mojoScore_3960622.png", "date": "2026-04-24 10:10:31", "description": "Aarti Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Aarti Drugs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-3944595", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiDrugsLtd_mojoScore_3944595.png", "date": "2026-04-13 10:10:32", "description": "Aarti Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-3935412", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiDrugsLtd_technicaldot_3935412.png", "date": "2026-04-07 08:03:09", "description": "Aarti Drugs Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting nuanced changes in key indicators such as MACD, RSI, and moving averages. Despite a modest day gain of 1.12%, the pharmaceutical company’s technical landscape remains complex, with mixed signals across weekly and monthly charts suggesting cautious investor sentiment amid broader market challenges." }, { "title": "Aarti Drugs Ltd Gains 6.49%: Two Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-gains-649-two-key-factors-driving-the-weekly-rally-3932160", "imagepath": "", "date": "2026-04-04 16:05:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> Stock drops 3.39% amid broad market weakness</p>\n <p><strong>1 Apr:</strong> Intraday high of Rs.344.20 with 7.65% gain</p>\n <p><strong>2 Apr:</strong> Investment rating upgraded to Sell, stock rises 1.37%</p>\n <p><strong>3 Apr:</strong> No trading data available, week closes at Rs.352.05</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.330.60</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.352.05</div><div cl..." }, { "title": "Aarti Drugs Ltd Investment Rating Upgraded to Sell on Improving Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-investment-rating-upgraded-to-sell-on-improving-fundamentals-3929626", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiDrugsLtd_mojoScore_3929626.png", "date": "2026-04-02 08:16:14", "description": "Aarti Drugs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, reflecting a nuanced reassessment of its financial performance, valuation metrics, management efficiency, and technical indicators. Despite ongoing challenges in profitability and operating trends, certain valuation and efficiency parameters have improved, prompting a more balanced outlook for this small-cap pharmaceutical player." }, { "title": "Aarti Drugs Ltd Surges 7.65% to Day's High of Rs 344.2 — Outperforms Sector by 6.28 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-hits-intraday-high-with-765-surge-on-1-april-2026-3928852", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiDrugsLtd_priceRelatedfactors_3928852.png", "date": "2026-04-01 10:45:59", "description": "The Sensex declined by 2.15% on 1 Apr 2026, yet Aarti Drugs Ltd surged 7.65%, marking a 6.28 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a genuine recovery or a technical bounce within a broader downtrend." }, { "title": "Aarti Drugs Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-strong-sell-3927213", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AartiDrugsLtd_mojoScore_3927213.png", "date": "2026-03-31 10:10:37", "description": "Aarti Drugs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Aarti Drugs Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-strong-sell-3902715", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AartiDrugsLtd_mojoScore_3902715.png", "date": "2026-03-20 10:10:45", "description": "Aarti Drugs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 684, "sid": "657348", "stock_news_url": "https://www.marketsmojo.com/news/aarti-drugs-657348" }, "announcements": [ { "details": "Disclosure under SEBI Takeover Regulations AARTIDRUGS : Seema Harshit Savla has submitted to the Exchange, vide letter dated November 21, 2019 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.", "source": "NSE", "caption": "Aarti Drugs Limited - Disclosure under SEBI Takeover Regulations", "datetime": "22-Nov-2019" }, { "details": "Aarti Drugs Limitedany namely Aarti Speciality Chemicals Limited CIN No: U24230MH2019PLC333306 on November 20, 2019.", "source": "NSE", "caption": "Aarti Drugs Limited - Acquisition", "datetime": "21-Nov-2019" }, { "details": "Disclosure under SEBI Takeover Regulations AARTIDRUGS : Seema Harshit Savla has submitted to the Exchange vide letter dated November 07, 2019 a copy of Disclosure as per Regulation 10(5) of SEBI (SAST) Regulation 2011", "source": "NSE", "caption": "Aarti Drugs Limited - Disclosure under SEBI Takeover Regulations", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aarti Drugs Ltd has declared <strong>20%</strong> dividend, ex-date: 09 Feb 26", "dt": "2026-02-09", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aarti Drugs Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 30 Sep 20", "dt": "2020-09-30", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: Stock drops 3.39% amid broad market weakness

1 Apr: Intraday high of Rs.344.20 with 7.65% gain

2 Apr: Investment rating upgraded to Sell, stock rises 1.37%

3 Apr: No trading data available, week closes at Rs.352.05

Read full news article

Aarti Drugs Ltd Investment Rating Upgraded to Sell on Improving Fundamentals

2026-04-02 08:16:14

Aarti Drugs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, reflecting a nuanced reassessment of its financial performance, valuation metrics, management efficiency, and technical indicators. Despite ongoing challenges in profitability and operating trends, certain valuation and efficiency parameters have improved, prompting a more balanced outlook for this small-cap pharmaceutical player.

Read full news article

Aarti Drugs Ltd Surges 7.65% to Day's High of Rs 344.2 — Outperforms Sector by 6.28 Percentage Points

2026-04-01 10:45:59

The Sensex declined by 2.15% on 1 Apr 2026, yet Aarti Drugs Ltd surged 7.65%, marking a 6.28 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a genuine recovery or a technical bounce within a broader downtrend.

Read full news article

Aarti Drugs Ltd is Rated Strong Sell

2026-03-31 10:10:37

Aarti Drugs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Aarti Drugs Ltd is Rated Strong Sell

2026-03-20 10:10:45

Aarti Drugs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article